Addex Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $36 | $71 | $1 | $53 |
Gross Profit | 36 | -85 | 53 | |
EBITDA | -730 | -1,470 | -1,473 | |
EBIT | -732 | -1,472 | -445 | -1,526 |
Net Income | -1,841 | -1,472 | -1,205 | -1,529 |
Net Change In Cash | 36 | 71 | 1 | 53 |
Free Cash Flow | -419 | -598 | -23 | -399 |
Cash | 2,300 | 2,825 | 3,341 | 3,349 |
Basic Shares | 767 | 819 | 128,292 | 812 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $410 | $1,612 | $1,422 | $2,916 |
Gross Profit | -444 | 430 | -13,201 | -9,665 |
EBITDA | -4,645 | -10,228 | -10,532 | -14,941 |
EBIT | -4,905 | -10,534 | -10,540 | -15,288 |
Net Income | 7,055 | -10,556 | -20,804 | -15,351 |
Net Change In Cash | 410 | 1,612 | 1,422 | 2,916 |
Free Cash Flow | -5,374 | -7,999 | -16,437 | -14,736 |
Cash | 3,341 | 3,865 | 6,957 | 20,484 |
Basic Shares | 817 | 619 | 376 | 284 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$2.66 |
2025-03-31 | -$0.01 |
2024-09-30 | $10.17 |
2024-03-31 | -$4.05 |
